A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : HDFN / hemolytic disease of the fetus and newborn

[Related PubMed/MEDLINE]
Total Number of Papers: 199
[Display Entries]
100 entries :
     (Publication year, Descending)
100 entries :
     (Publication year, Ascending)
>> all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   HDFN  (>> Co-occurring Abbreviation)
Long Form:   hemolytic disease of the fetus and newborn
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
1  2022 Estimating the risks of prehospital transfusion of D-positive whole blood to trauma patients who are bleeding in England. CBP, CI, LTOWB
2  2022 Hemolytic disease of the fetus and newborn in the sensitizing pregnancy where anti-D was incorrectly identified as RhIG. ---
3  2022 Noninvasive diagnostics of fetal KEL*01.01 allele from maternal plasma of immunized women using digital PCR protocols. NIPT, PCR
4  2022 Population-based incidence and risk factors for cholestasis in hemolytic disease of the fetus and newborn. ---
5  2022 Retrospective analysis of direct antiglobulin test positivity at tertiary academic hospital over 10 years. DAT, ET, IVIG
6  2022 RHD Genotyping of Rh-Negative and Weak D Phenotype among Blood Donors in Southeast Iran. HTR
7  2022 Routine noninvasive prenatal screening for fetal Rh D in maternal plasma-A 2-year experience from a single center in Belgium. RhD, RhIG
8  2021 ABO haemolytic disease of the newborn: Improved prediction by novel integration of causative and protective factors in newborn and mother. ---
9  2021 An Easy Multiplex PCR-SSP Assay for the Genotyping of KEL1 and KEL2 in Multi-transfused Patients. ---
10  2021 Conservative Management of Alloimmune Hemolysis and Cholestasis With Extreme Laboratory Abnormalities. ---
11  2021 D--phenotype due to RHD-RHCE hybrid transcript in a case of severe haemolytic disease of newborn with anti-Rh 17(Hrₒ) antibodies. HTR
12  2021 Exchange transfusions in severe Rh-mediated alloimmune haemolytic disease of the foetus and newborn: a 20-year overview on the incidence, associated risks and outcome. ETs
13  2021 HDFN Resulting from Anti-U: Alternatives to Allogeneic Intrauterine Transfusion. ---
14  2021 Hemolytic disease and reticulocytopenia of the newborn attributable to maternal immunoglobulin G anti-M reacting optimally at cold temperatures. DAT, Ig, RBCs
15  2021 Hemolytic disease in fetuses and newborns due to antibodies against the M-antigen ---
16  2021 Hemolytic Disease of the Fetus and Newborn: Historical and Current State. ---
17  2021 Hydrops fetalis with isolated massive ascites in apreterm neonate with rhesus disease. NICU
18  2021 Hyporegenerative anemia in anti-M-associated hemolytic disease of the fetus. RPIs
19  2021 Laboratory Monitoring of Mother, Fetus, and Newborn in Hemolytic Disease of Fetus and Newborn. GA
20  2021 Management and clinical consequences of red blood cell antibodies in pregnancy: A population-based cohort study. IUT, RBC
21  2021 Maternal red blood cell alloimmunisation Working Party, literature review. RH blood group system: Rare specificities. ---
22  2021 Navigating the challenges of Bombay phenotype (Oh ) and twin pregnancy; a case report and literature review. PPH
23  2021 Non-Invasive Prenatal Fetal Blood Group Genotype and Its Application in the Management of Hemolytic Disease of Fetus and Newborn: Systematic Review and Meta-Analysis. NIPT
24  2021 Perinatal risk factors associated with severity of haemolytic disease of the foetus and newborn due to Rhc maternal-foetal incompatibility: A retrospective cohort study. AUC
25  2021 Prevalence and Specificity of Red Cell Alloantibodies in Un-Transfused Multiparous Women. ---
26  2021 Prevalence of rhesus D-negative blood type and the challenges of rhesus D immunoprophylaxis among obstetric population in Ethiopia: a systematic review and meta-analysis. FMH, HDN, KBT
27  2021 Prognostic Significance and Prevalence of IgG Subtypes in Rh Haemolytic Disease of Fetus and Newborn. ---
28  2021 Risk Minimization of Hemolytic Disease of the Fetus and Newborn Using Droplet Digital PCR Method for Accurate Fetal Genotype Assessment of RHD, KEL, and RHCE from Cell-Free Fetal DNA of Maternal Plasma. dd
29  2021 School performance and behavioral functioning in children after intrauterine transfusions for hemolytic disease of the fetus and newborn. CBCL, IUT, TRF
30  2021 Statistical model for prediction of ABO hemolytic disease of the fetus and newborn inIndia. ---
31  2021 The combined effect of anti-D and non-D Rh antibodies in maternal alloimmunization IUT
32  2021 The effect of extended c, E and K matching in females under 45 years of age on the incidence of transfusion-induced red blood cell alloimmunisation. CI, RBC
33  2021 The Evolving Application of DNA-Based Genotyping of Red Blood Cells in Blood Grouping: A Narrative Review. ---
34  2021 The risk to future pregnancies of transfusing Rh(D)-negative females of childbearing potential with Rh(D)-positive red blood cells during trauma resuscitation is dependent on their age at transfusion. FCP, RBC
35  2021 The role of non-invasive prenatal testing (NIPT) for fetal blood group typing in Australia. NIPT, RhD
36  2021 [Severe foetal anaemia caused by undetected alloimmunisation in a RhD-positive pregnant woman]. ---
37  2020 A case report of haemolytic disease of the foetus and newborn caused by Alloantibody D and Jka in a Rhesus D negative Nigerian woman: Justification for the implementation of universal access to prophylaxis and evidenced-based best practices. FMH
38  2020 Clinical consequences of the extremely rare anti-PP1Pk isoantibodies in pregnancy: a case series and review of the literature. TPE
39  2020 Distribution of maternal red cell antibodies and the risk of severe alloimmune haemolytic disease of the foetus in a Chinese population: a cohort study on prenatal management. HDF
40  2020 Feasibility assessment for use of Rh-positive blood products during emergency resuscitation in the North Texas trauma population. ---
41  2020 Frequency and clinical significance of red cell antibodies in pregnancy - A prospective study from India. ---
42  2020 Hemolytic Disease of Fetus and Newborn in a Primigravida with Multiple Alloantibodies Involving Anti-Jka and Anti-E: A Case Report. ---
43  2020 Hemolytic Disease of the Fetus and Newborn Caused by Anti-Group A IgG From a Group B Mother. ---
44  2020 Hemolytic disease of the fetus and newborn caused by anti-Hr0 in a 27-year-old female with Dc- phenotype: A case report. IgG, IVIG
45  2020 Hemolytic Disease of the Fetus and Newborn Caused by Maternal Autoantibody with Mimicking Anti-E Specificity. ---
46  2020 Hemolytic disease of the fetus and newborn due to multiple alloantibodies in pregnancy. ---
47  2020 Immunological principle of development of red blood cell alloimmunization in pregnancy, hemolytic disease of the fetus and prevention of RhD alloimmunization in RhD negative women. AMIS, Ig
48  2020 Impact of red blood cell alloimmunization on fetal and neonatal outcomes: A single center cohort study. DAT, IUTs
49  2020 Medical therapy to attenuate fetal anaemia in severe maternal red cell alloimmunisation. IVIG
50  2020 Molecular characterization of rare D--/D-- variants in individuals of Indian origin. PCR, QMPSF
51  2020 Next Generation Sequencing-Based Fetal ABO Blood Group Prediction by Analysis of Cell-Free DNA from Maternal Plasma. NGS
52  2020 Non-invasive prenatal testing for management of haemolytic disease of the fetus and newborn induced by maternal alloimmunisation. NIPT
53  2020 Prevalence of Rhesus C and D Alloantibodies among Rhesus-Negative Women of Child Bearing Age at a Tertiary Hospital in South-West Nigeria. Rh
54  2020 Red blood cell alloimmunization prevalence and hemolytic disease of the fetus and newborn in Israel: A retrospective study. RBC
55  2020 Severe hemolytic disease of the fetus and newborn due to anti-E and anti-Jka. ---
56  2020 Successful prenatal management of two foetuses affected by antibodies against GP.Mur with prenatal genotyping analysis and a literature review. B-A-B
57  2020 The Outcome of Hemolytic Disease of the Fetus and Newborn Caused by Anti-Rh17 Antibody: Analysis of Three Cases and Review of the Literature. RBC
58  2020 The rhesus incompatible pregnancy and its consequences for affected fetuses and neonates. IUT
59  2020 Three non-classical mechanisms for anemic disease of the fetus and newborn, based on maternal anti-Kell, anti-Ge3, anti-M, and anti-Jra cases. ADFN
60  2019 A case of mild HDFN caused by anti-C, anti-D, and anti-G: Diagnostic strategy and clinical significance of distinguishing anti-G from anti-D and anti-C. Rh
61  2019 A case report on anti-Mia antibody in a multi-transfused patient from India. ---
62  2019 Anemic Disease of the Newborn With Little Increase in Hemolysis and Erythropoiesis Due to Maternal Anti-Jra: A Case Study and Review of the Literature. DAT
63  2019 Cold reacting anti-M causing delayed hemolytic disease of the newborn. RBC
64  2019 Conservative Management of Hyperferritinemia in Hemolytic Disease of the Fetus and Newborn: A Case Report and Review of the Literature. ---
65  2019 Diagnostic value of laboratory monitoring to predict severe hemolytic disease of the fetus and newborn in non-D and non-K-alloimmunized pregnancies. ADCC, PPV, RBC
66  2019 Exchange transfusion in neonatal hyperbilirubinemia: A single Centre experience from Northern India. ET, NNH, RB, TSB
67  2019 Fatal hemolytic disease of the fetus and newborn caused by anti-Jra antibody: A case report and literature review. ---
68  2019 Identification of red blood cell antibodies in maternal breast milk implicated in prolonged hemolytic disease of the fetus and newborn. AHG, RBC
69  2019 Knowledge, attitude and practices of obstetric care providers towards maternal red-blood-cell immunization during pregnancy. KAP
70  2019 Molecular Detection of Glycophorins A and B Variant Phenotypes and their Clinical Relevance. GYPA, GYPB, HTR, LAMP, PCR
71  2019 Necrotizing enterocolitis in haemolytic disease of the newborn: a retrospective cohort study. NEC
72  2019 Neonatal Alloimmune Neutropenia. FNAIT
73  2019 Predicting anaemia and transfusion dependency in severe alloimmune haemolytic disease of the fetus and newborn in the first 3months after birth. CI, IUT, OR
74  2019 Prevalence and specificity of clinically significant red cell alloantibodies in pregnant women - a study from a tertiary care hospital in Southeast Michigan. ---
75  2019 Recurrent fetal hydrops with maternal M alloimmunisation: not a benign condition. ---
76  2019 Rhesus D alloimmunization in pregnancy from 1996 to 2015 in Iceland: a nation-wide population study prior to routine antenatal anti-D prophylaxis. DAT, IUT, RAADP, RhD
77  2019 Severe ABO hemolytic disease of fetus and newborn requiring blood exchange transfusion. DAT, ETs
78  2019 Severe anti-D haemolytic disease of fetal and newborn in rhesus D negative primigravida. ---
79  2019 Severe Fetal Hemolysis and Cholestasis Due to High-Titer Maternal IgG Anti-A Antibodies. ---
80  2019 Severe haemolytic disease of a newborn with variant D mimicking blocked-D phenomenon. ---
81  2019 The prenatal intervention of pregnancy complicated with anti-Kell isoimmunization: a review. ---
82  2018 ABO incompatibility and RhIG immunoprophylaxis protect against non-D alloimmunization by pregnancy. CI
83  2018 Bombay phenotype (Oh ) and high-titer anti-H in pregnancy: two case reports and a review of the literature. Hb, PBM
84  2018 Frequency of Red Cell Alloantibodies in Pregnant Females of Navsari District: An Experience that Favours Inclusion of Screening for Irregular Erythrocyte Antibody in Routine Antenatal Testing Profile. ---
85  2018 Hemolytic disease of the fetus and newborn due to alloanti-M: three Chinese case reports and a review of the literature. ---
86  2018 Intrauterine Fetal Blood Transfusion: Descriptive study of the first four years' experience in Oman. IUT
87  2018 Jk3 alloantibodies during pregnancy-blood bank management and hemolytic disease of the fetus and newborn risk. MCA
88  2018 Management of pregnancy sensitized with anti-Inb with monocyte monolayer assay and maternal blood donation. RBC
89  2018 Molecular characterization and multidisciplinary management of Gerbich hemolytic disease of the newborn. Ge, GYPC
90  2018 Red Blood Cell Alloimmunization in the Pregnant Patient. RBC
91  2018 Red blood cells, still vital after all these years: Commentary on Canadian Blood Services' International Symposium 2017. CBS, RBC
92  2018 Retrospective analysis of HDFN due to ABO incompatibility in a single institution over 6 years. DAT
93  2018 Severe hemolytic disease of the fetus and newborn due to allo-anti-D in a patient with a partial DEL phenotype arising from the variant allele described as RHD*148+1T (RHD*01EL.31). ---
94  2017 A descriptive single-centre experience of the management and outcome of maternal alloantibodies in pregnancy. GSTFT
95  2017 Anti-D in a mother, hemizygous for the variant RHD*DNB gene, associated with hemolytic disease of the fetus and newborn. RBCs
96  2017 Anti-M induced severe haemolytic disease of foetus and newborn in a Malay woman with recurrent pregnancy loss. RBC
97  2017 Blood Group Antigen Matching Influence on Gestational Outcomes (AMIGO) study. AMIGO, FCP, RBC
98  2017 D antibodies in pregnant women in multiethnic Suriname: the observational RheSuN study. ADCC, RBC
99  2017 Enhanced opsonisation of Rhesus D-positive human red blood cells by recombinant polymeric immunoglobulin G anti-G antibodies. anti-D, Ig
100  2017 Intrauterine transfusion and non-invasive treatment options for hemolytic disease of the fetus and newborn - review on current management and outcome. IUT